News from the catapult network

News headlines from across the Catapult Network. For comprehensive news updates, please explore our Politics Home webpage or visit individual Catapult websites

Graphic of four images including a microscope, a solar panel, a man examining a samply and a flying drone
Catapult Network
NEWS
Catapulting growth in 2023 and beyond
In the face of many challenges – changing customer desires, cost pressures, supply chain disruption, expected regulatory changes and fierce competition – UK innovation is on the rise. This article showcases how Catapults helped to deliver great results for business and industry in 2023; it summarises our predictions for technology-driven advances in 2024 and the years ahead.
Read more
Medicines Discovery
alt=
News
Global AMR Challenge Receives a £5m Boost to Drive Diagnostics Innovation
PACE (Pathways to Antimicrobial Clinical Efficacy) has today launched its second funding round with up to £5 million available to support cutting-edge diagnostic projects. This funding is part of a broader £30 million investment to address the global challenge of antimicrobial resistance (AMR).
Read more
Medicines Discovery
News
Global AMR Challenge Receives a £5m Boost to Drive Diagnostics Innovation
PACE (Pathways to Antimicrobial Clinical Efficacy) has today launched its second funding round with up to £5 million available to support cutting-edge diagnostic projects. This funding is part of a broader £30 million investment to address the global challenge of antimicrobial resistance (AMR).
Read more
Medicines Discovery
Graphic for CF AMR Syndicate Collaborative Discovery Programme
News
CF AMR Syndicate Announces First Awardees of £3m Collaborative Drug Discovery Programme
The Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate has today announced the first cohort of awardees of its Collaborative Discovery Programme (CDP) funding. The £3 million programme, funded by LifeArc, will support six early-stage novel antimicrobial projects over two years to accelerate new treatments for lung infections in people with CF.
Read more